Which pharmacologic agents are recommended for severe post‑herpetic neuralgia?

Recommended Medications for Severe Post-Herpetic Neuralgia

For severe post-herpetic neuralgia, tricyclic antidepressants (particularly nortriptyline) are the most effective first-line treatment with the strongest evidence (NNT = 2.64), followed by gabapentin or pregabalin as alternatives, with topical lidocaine patches and capsaicin as adjunctive therapies. 1

First-Line Systemic Agents

Tricyclic Antidepressants (TCAs) - Highest Efficacy

• TCAs demonstrate the strongest analgesic efficacy for post-herpetic neuralgia with a number needed to treat (NNT) of 2.64, making them superior to other oral agents 1
• Nortriptyline is preferred over amitriptyline due to better tolerability with fewer anticholinergic side effects (sedation, dry mouth, urinary hesitancy), while maintaining similar efficacy 2, 3
• Start nortriptyline at 10-25 mg at bedtime, increase every 3-7 days to a final dose of 25-100 mg at bedtime as tolerated 2, 3
• Desipramine is an alternative secondary amine TCA with similar tolerability to nortriptyline 2, 4
• Pain relief typically occurs within 3 weeks, with 66% of patients experiencing significant improvement 3

Gabapentinoids - Alternative First-Line

• Gabapentin has an NNT of 4.39 for post-herpetic neuralgia, making it less effective than TCAs but still a valid first-line option 1

• Start at 100-300 mg nightly, increase by 50-100% every few days to 900-3600 mg daily in 2-3 divided doses 2

• Slower titration is required for elderly or medically frail patients 2

• Dose adjustment is mandatory for renal insufficiency 2

• Pregabalin has an NNT of 4.93 and offers more efficient GI absorption with linear pharmacokinetics, allowing easier titration 1, 2

• Start at 50 mg three times daily, increase to 100 mg three times daily after 1-2 weeks 2, 5

• Maximum dose is 600 mg daily in divided doses, though 300 mg/day is often sufficient 2, 5

• Consider pregabalin if inadequate response to gabapentin 1

Topical Agents - Essential Adjuncts

Lidocaine Patches

• 5% lidocaine patches have an NNT of 2.0, matching the efficacy of TCAs with superior tolerability 1
• Apply daily to the painful site with minimal systemic absorption 2
• Particularly effective for well-localized pain with allodynia 5
• Mild local reactions are the only common adverse effects, making this ideal for elderly patients 5

Capsaicin

• Capsaicin 0.075% has an NNT of 3.26 for post-herpetic neuralgia 1
• 8% capsaicin dermal patch provides pain relief for at least 12 weeks after a single 30-minute application 1
• Pre-treat with 60 minutes of 4% lidocaine application before capsaicin to minimize erythema and pain 1

Second-Line Opioid Therapy

When to Consider Opioids

• Reserve for patients with moderate to severe pain who fail first-line therapies 1
• Opioids should NOT be first-line agents due to risks of cognitive impairment, respiratory depression, and addiction 1

Specific Opioid Recommendations

• Oxycodone, extended-release morphine, and methadone have an NNT of 2.67, demonstrating strong efficacy 1
• Tramadol has an NNT of 4.76 and carries lower abuse potential than traditional opioids 1, 5
• Start tramadol at 50 mg once or twice daily, increase by 50-100 mg/day every 3-7 days to maximum 400 mg/day (300 mg/day in patients >75 years) 5
• Combination regimen of morphine and gabapentin should be considered for additive effects and lower individual doses 1

Treatment Algorithm for Severe PHN

1. Initiate nortriptyline 10-25 mg at bedtime as primary systemic agent 2, 3
2. Add 5% lidocaine patches to painful areas for immediate localized relief 2, 5
3. If inadequate response after 3-4 weeks, add or switch to gabapentin (titrate to 900-3600 mg/day) or pregabalin (150-600 mg/day) 2, 5
4. Consider 8% capsaicin patch for additional topical therapy if pain persists 1
5. For refractory severe pain, add tramadol or consider stronger opioids (oxycodone, morphine) as second/third-line therapy 1
6. Combination therapy is often necessary for optimal pain control in severe cases 3, 6

Critical Considerations

• Age is the most important risk factor for post-herpetic neuralgia, with 50% of patients >50 years and 75% of patients >75 years developing PHN 7, 8
• Early initiation of treatment (within 72 hours of rash onset with antivirals, and early gabapentin or amitriptyline) reduces PHN risk 4, 9
• Anticholinergic side effects (sedation, dry mouth, urinary retention) are more problematic in elderly patients with TCAs, necessitating slow titration 2, 3
• Somnolence and dizziness are common with gabapentinoids and can be problematic in older adults 10
• Renal function must be assessed before initiating gabapentin or pregabalin, with dose adjustments required for impairment 2
• Pain can persist for years despite treatment, requiring long-term management strategies 6, 11